{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:42:00Z","timestamp":1794411720627,"version":"4.9.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Khoy University of Medical Sciences","award":["IR.KHOY.REC.1403.029"],"award-info":[{"award-number":["IR.KHOY.REC.1403.029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05697-z","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:23:21Z","timestamp":1769682201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis"],"prefix":"10.1007","volume":"63","author":[{"given":"Masoud","family":"Nikanfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Nourazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"5697_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104970","volume":"101","author":"MS Freedman","year":"2024","unstructured":"Freedman MS, Gnanapavan S, Booth RA, Calabresi PA, Khalil M, Kuhle J, Lycke J, Olsson T (2024) Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management. EBioMedicine 101:104970. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104970","journal-title":"EBioMedicine"},{"issue":"14","key":"5697_CR2","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1038\/s41433-024-03132-y","volume":"38","author":"A Suh","year":"2024","unstructured":"Suh A, Hampel G, Vinjamuri A, Ong J, Kamran SA, Waisberg E, Paladugu P, Zaman N et al (2024) Oculomics analysis in multiple sclerosis: current ophthalmic clinical and imaging biomarkers. Eye 38(14):2701\u20132710. https:\/\/doi.org\/10.1038\/s41433-024-03132-y","journal-title":"Eye"},{"key":"5697_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/neo2.10","author":"R Agarwal","year":"2024","unstructured":"Agarwal R, Risk BB, Sandlin DS, Mulamalla AR, Sadigh G, Allen JW, Fleischer CC (2024) Effects of financial toxicity and socioeconomic status on MRI follow\u2010up time in multiple sclerosis. Clin Neuroimaging. https:\/\/doi.org\/10.1002\/neo2.10","journal-title":"Clin Neuroimaging"},{"key":"5697_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1532660","volume":"16","author":"V Fleischer","year":"2025","unstructured":"Fleischer V, Brummer T, Muthuraman M, Steffen F, Heldt M, Protopapa M, Schraad M, Gonzalez-Escamilla G et al (2025) Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis. Front Immunol 16:1532660. https:\/\/doi.org\/10.3389\/fimmu.2025.1532660","journal-title":"Front Immunol"},{"issue":"1","key":"5697_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10571-025-01578-6","volume":"45","author":"ER Asl","year":"2025","unstructured":"Asl ER, Hosseini SE, Tahmasebi F, Bolandi N, Barati S (2025) MiR-124 and MiR-155 as therapeutic targets in microglia-mediated inflammation in multiple sclerosis. Cell Mol Neurobiol 45(1):63. https:\/\/doi.org\/10.1007\/s10571-025-01578-6","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"5697_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05372-8","volume":"15","author":"M Nikanfar","year":"2025","unstructured":"Nikanfar M, Nouri M, Hassanpour M, Rezaei J, Nourazarian A (2025) Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development. Sci Rep 15(1):23523. https:\/\/doi.org\/10.1038\/s41598-025-05372-8","journal-title":"Sci Rep"},{"issue":"3","key":"5697_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.33631\/sabd.1560606","volume":"15","author":"D Koruyucu","year":"2025","unstructured":"Koruyucu D, Can Demird\u00f6\u011fen B (2025) Exploring miRNA inhibiting therapeutic strategies for multiple sclerosis: insights from experimental autoimmune encephalomyelitis studies \u2013 a traditional review. Sa\u011fl\u0131k Bilimlerinde De\u011fer 15(3):498\u2013508. https:\/\/doi.org\/10.33631\/sabd.1560606","journal-title":"Sa\u011fl\u0131k Bilimlerinde De\u011fer"},{"issue":"1","key":"5697_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-025-01438-2","volume":"15","author":"N Sanadgol","year":"2025","unstructured":"Sanadgol N, Samadi M, Voelz C, Khalseh R, Amini J, Beyer C, Kipp M, Clarner T (2025) Genomic ncRNAs regulating mitochondrial function in neurodegeneration: a neglected clue in the complex etiopathogenesis of multiple sclerosis. Cell Biosci 15(1):93. https:\/\/doi.org\/10.1186\/s13578-025-01438-2","journal-title":"Cell Biosci"},{"issue":"1","key":"5697_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03234-3","volume":"16","author":"MJ Yousefi","year":"2025","unstructured":"Yousefi MJ, Afshar Y, Amoozadehsamakoosh A, Naseri A, Soltani F, Yazdanpanah N, Saleki K, Rezaei N (2025) Interplay between innate-like T-cells and microRNAs in cancer immunity. Discov Oncol 16(1):1425. https:\/\/doi.org\/10.1007\/s12672-025-03234-3","journal-title":"Discov Oncol"},{"key":"5697_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132172","author":"E Zare","year":"2025","unstructured":"Zare E, Yaghoubi SM, Khoshnazar M, Jafari Dargahlou S, Machhar JS, Zheng Z, Duijf PHG et al (2025) MicroRNAs in cancer immunology: master regulators of the tumor microenvironment and immune evasion, with therapeutic potential. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers17132172","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5697_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02994-5","volume":"20","author":"T Gauthier","year":"2023","unstructured":"Gauthier T, Martin-Rodriguez O, Chague C, Daoui A, Ceroi A, Varin A, Bonnefoy F, Valmary-Degano S et al (2023) Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors. J Neuroinflammation 20(1):307. https:\/\/doi.org\/10.1186\/s12974-023-02994-5","journal-title":"J Neuroinflammation"},{"key":"5697_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1154211","volume":"14","author":"E Ahlberg","year":"2023","unstructured":"Ahlberg E, Al-Kaabawi A, Thune R, Simpson MR, Pedersen SA, Cione E, Jenmalm MC, Tingo L (2023) Breast milk microRNAs: potential players in oral tolerance development. Front Immunol 14:1154211. https:\/\/doi.org\/10.3389\/fimmu.2023.1154211","journal-title":"Front Immunol"},{"key":"5697_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/09636897221148775","volume":"32","author":"YJ Liu","year":"2023","unstructured":"Liu YJ, Miao HB, Lin S, Chen Z (2023) Current progress in treating systemic lupus erythematosus using exosomes\/microRNAs. Cell Transplant 32:9636897221148775. https:\/\/doi.org\/10.1177\/09636897221148775","journal-title":"Cell Transplant"},{"issue":"2","key":"5697_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/10738584241254118","volume":"31","author":"Q Shi","year":"2025","unstructured":"Shi Q, Gutierrez RA, Bhat MA (2025) Microglia, Trem2, and neurodegeneration. Neuroscientist 31(2):159\u2013176. https:\/\/doi.org\/10.1177\/10738584241254118","journal-title":"Neuroscientist"},{"key":"5697_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1579511","volume":"19","author":"J Doroszkiewicz","year":"2025","unstructured":"Doroszkiewicz J, Winkel I, Mroczko B (2025) Comparative analysis of neuroinflammatory pathways in Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis: insights into similarities and distinctions. Front Neurosci 19:1579511. https:\/\/doi.org\/10.3389\/fnins.2025.1579511","journal-title":"Front Neurosci"},{"key":"5697_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1554398","volume":"17","author":"C He","year":"2025","unstructured":"He C, Chen B, Yang H, Zhou X (2025) The dual role of microglia in Alzheimer\u2019s disease: from immune regulation to pathological progression. Front Aging Neurosci 17:1554398. https:\/\/doi.org\/10.3389\/fnagi.2025.1554398","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"5697_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","volume":"81","author":"AH Cross","year":"2024","unstructured":"Cross AH, Gelfand JM, Thebault S, Bennett JL, von Budingen HC, Cameron B, Carruthers R, Edwards K et al (2024) Emerging cerebrospinal fluid biomarkers of disease activity and progression in multiple sclerosis. JAMA Neurol 81(4):373\u2013383. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0017","journal-title":"JAMA Neurol"},{"issue":"1","key":"5697_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06799-3","volume":"23","author":"H Yu","year":"2025","unstructured":"Yu H, Zhang L, Song B, Ren K, Chen X, Dai Y, Yang Y, Xu Y et al (2025) TREM2-mediated regulation of microglial activity: a promising target for the treatment of ischemic stroke. J Transl Med 23(1):782. https:\/\/doi.org\/10.1186\/s12967-025-06799-3","journal-title":"J Transl Med"},{"key":"5697_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550893","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Wang Y, Yang L, Zhang Y, Yang L (2025) TREM2(+) macrophages: a key role in disease development. Front Immunol 16:1550893. https:\/\/doi.org\/10.3389\/fimmu.2025.1550893","journal-title":"Front Immunol"},{"key":"5697_CR20","unstructured":"McCray TJ (2025) The role of TREM2 and the responses mediated by Galectin-3 during age-related myelin degeneration. Indiana University-Purdue University Indianapolis"},{"key":"5697_CR21","unstructured":"Rinaldi A (2025) Microglia derived extracellular vesicles (EVs) in brain aging: a rejuvenation approach. Sapienza University of Rome"},{"key":"5697_CR22","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-25-00274","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yin P, Chen Q, Zhang Y, Tang Y, Jin W, Yu L (2025) Neurodegenerative diseases and immune system: from pathogenic mechanism to therapy. Neural Regen Res. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00274","journal-title":"Neural Regen Res"},{"key":"5697_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1495529","volume":"16","author":"P Vermersch","year":"2025","unstructured":"Vermersch P, Airas L, Berger T, Deisenhammer F, Grigoriadis N, Hartung HP, Magyari M, Popescu V et al (2025) The role of microglia in multiple sclerosis: implications for treatment with Bruton\u2019s tyrosine kinase inhibitors. Front Immunol 16:1495529. https:\/\/doi.org\/10.3389\/fimmu.2025.1495529","journal-title":"Front Immunol"},{"issue":"1","key":"5697_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03432-4","volume":"22","author":"BM Bettcher","year":"2025","unstructured":"Bettcher BM, de Oliveira FF, Willette AA, Michalowska MM, Machado LS, Rajbanshi B, Borelli WV, Tansey MG et al (2025) Analysis and interpretation of inflammatory fluid markers in Alzheimer\u2019s disease: a roadmap for standardization. J Neuroinflammation 22(1):105. https:\/\/doi.org\/10.1186\/s12974-025-03432-4","journal-title":"J Neuroinflammation"},{"issue":"6","key":"5697_CR25","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41380-025-02939-9","volume":"30","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, Gauthier S, Chandekar SA, Hviid Hahn-Pedersen J, Bentsen MA, Zetterberg H (2025) Neuroinflammatory fluid biomarkers in patients with Alzheimer\u2019s disease: a systematic literature review. Mol Psychiatry 30(6):2783\u20132798. https:\/\/doi.org\/10.1038\/s41380-025-02939-9","journal-title":"Mol Psychiatry"},{"issue":"1","key":"5697_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02796-9","volume":"20","author":"AHYS Hok","year":"2023","unstructured":"Hok AHYS, Del Campo M, Boiten WA, Stoops E, Vanhooren M, Lemstra AW, van der Flier WM, Teunissen CE (2023) Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer\u2019s disease. J Neuroinflammation 20(1):107. https:\/\/doi.org\/10.1186\/s12974-023-02796-9","journal-title":"J Neuroinflammation"},{"key":"5697_CR27","doi-asserted-by":"publisher","unstructured":"Asih PR, Morris CW, Wang H, Pedrini S, Goozee K, Laws SM, Chatterjee P, Taddei K et al (2025) Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer\u2019s disease. preprint. https:\/\/doi.org\/10.1101\/2025.08.11.25333037","DOI":"10.1101\/2025.08.11.25333037"},{"issue":"1","key":"5697_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00834-z","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Xiang X, Li Y, Bu G, Chen XF (2025) TREM2 and sTREM2 in Alzheimer\u2019s disease: from mechanisms to therapies. Mol Neurodegener 20(1):43. https:\/\/doi.org\/10.1186\/s13024-025-00834-z","journal-title":"Mol Neurodegener"},{"key":"5697_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-03022-x","author":"T Maeda","year":"2025","unstructured":"Maeda T, Mizutani Y, Ohdake R, Nagao R, Kawabata K, Shima S, Ueda A, Ito M et al (2025) Elevated levels of cerebrospinal fluid soluble triggering receptor expressed on myeloid cells 2 in multiple system atrophy: a marker of disease-associated microglial activation. J Neural Transm (Vienna). https:\/\/doi.org\/10.1007\/s00702-025-03022-x","journal-title":"J Neural Transm (Vienna)"},{"key":"5697_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2023.106894","author":"C Bartley","year":"2024","unstructured":"Bartley C, Lombardo G, Jha MK, Chaumette B, Hagenberg J, Rey R, Leboyer M, Pariante CM (2024) Immune biomarkers in psychiatric illness: findings from the biomarker subgroup of the NSAS brain-immune interactions workshop. Psychoneuroendocrinology. https:\/\/doi.org\/10.1016\/j.psyneuen.2023.106894","journal-title":"Psychoneuroendocrinology"},{"key":"5697_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1569503","volume":"16","author":"S Anandan","year":"2025","unstructured":"Anandan S, Maciak K, Breinbauer R, Mostafavi S, Kvistad CE, Torkildsen O, Myhr KM (2025) Brain-derived blood biomarkers in multiple sclerosis-current trends and beyond. Front Immunol 16:1569503. https:\/\/doi.org\/10.3389\/fimmu.2025.1569503","journal-title":"Front Immunol"},{"key":"5697_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2025.1640594","volume":"19","author":"I Casanova","year":"2025","unstructured":"Casanova I, Dominguez-Mozo MI, Alvarez-Lafuente R (2025) Editorial: neuroanatomical and molecular biomarkers for multiple sclerosis progression and therapeutic response. Front Neuroanat 19:1640594. https:\/\/doi.org\/10.3389\/fnana.2025.1640594","journal-title":"Front Neuroanat"},{"issue":"1","key":"5697_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59337-4","volume":"14","author":"M Soleimani","year":"2024","unstructured":"Soleimani M, Thi M, Janfaza S, Ozcan G, Mazurek S, Ozgun G, Maurice-Dror C, Eigl B et al (2024) Circulating microrna-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma. Sci Rep 14(1):8603. https:\/\/doi.org\/10.1038\/s41598-024-59337-4","journal-title":"Sci Rep"},{"key":"5697_CR34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212479","author":"N Zhao","year":"2022","unstructured":"Zhao N, Qiao W, Li F, Ren Y, Zheng J, Martens YA, Wang X, Li L et al (2022) Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20212479","journal-title":"J Exp Med"},{"issue":"2","key":"5697_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"5697_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis - a review. Eur J Neurol 26(1):27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"issue":"10","key":"5697_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S1474-4422(24)00256-4","volume":"23","author":"J Correale","year":"2024","unstructured":"Correale J, Solomon AJ, Cohen JA, Banwell BL, Gracia F, Gyang TV, de Bedoya FHD, Harnegie MP et al (2024) Differential diagnosis of suspected multiple sclerosis: global health considerations. Lancet Neurol 23(10):1035\u20131049. https:\/\/doi.org\/10.1016\/S1474-4422(24)00256-4","journal-title":"Lancet Neurol"},{"key":"5697_CR38","doi-asserted-by":"publisher","first-page":"101009","DOI":"10.1016\/j.lanepe.2024.101009","volume":"44","author":"M Di Filippo","year":"2024","unstructured":"Di Filippo M, Gaetani L, Centonze D, Hegen H, Kuhle J, Teunissen CE, Tintore M, Villar LM et al (2024) Fluid biomarkers in multiple sclerosis: from current to future applications. Lancet Reg Health Eur 44:101009. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101009","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"5697_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ana.27145","volume":"97","author":"WJ Brownlee","year":"2025","unstructured":"Brownlee WJ, Vidal-Jordana A, Shatila M, Strijbis E, Schoof L, Killestein J, Barkhof F, Bollo L et al (2025) Towards a unified set of diagnostic criteria for multiple sclerosis. Ann Neurol 97(3):571\u2013582. https:\/\/doi.org\/10.1002\/ana.27145","journal-title":"Ann Neurol"},{"issue":"10","key":"5697_CR40","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.7150\/ijms.96851","volume":"21","author":"M Qian","year":"2024","unstructured":"Qian M, Zhong J, Lu Z, Zhang W, Weng M, Zhang K, Jin Y (2024) Bibliometric analysis of TREM2 (2001\u20132022): trends, hotspots and prospects in human disease. Int J Med Sci 21(10):1852\u20131865. https:\/\/doi.org\/10.7150\/ijms.96851","journal-title":"Int J Med Sci"},{"issue":"1","key":"5697_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33594\/000000814","volume":"32","author":"AH Abdullah","year":"2025","unstructured":"Abdullah AH (2025) Peripheral inflammation as a biomarker of disease activity in relapsing-remitting MS. Neurosignals 32(1):1\u201310. https:\/\/doi.org\/10.33594\/000000814","journal-title":"Neurosignals"},{"key":"5697_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1612703","volume":"16","author":"A Roy","year":"2025","unstructured":"Roy A, Zeller J, Nero TL, Klepetko J, Eisenhardt SU, Parker MW, McFadyen JD, Peter K (2025) C-reactive protein: the nexus between inflammation and protein misfolding diseases. Front Immunol 16:1612703. https:\/\/doi.org\/10.3389\/fimmu.2025.1612703","journal-title":"Front Immunol"},{"issue":"1","key":"5697_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03036-4","volume":"21","author":"E Kodosaki","year":"2024","unstructured":"Kodosaki E, Watkins WJ, Loveless S, Kreft KL, Richards A, Anderson V, Hurler L, Robertson NP et al (2024) Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes. J Neuroinflammation 21(1):52. https:\/\/doi.org\/10.1186\/s12974-024-03036-4","journal-title":"J Neuroinflammation"},{"issue":"4","key":"5697_CR44","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82579","volume":"17","author":"A Yacine","year":"2025","unstructured":"Yacine A, Zain Ali M, Alharbi AB, Qubayl Alanaz H, Saud Alrahili A, Alkhdairi AA (2025) Chronic inflammation: a multidisciplinary analysis of shared pathways in autoimmune, infectious, and degenerative diseases. Cureus 17(4):e82579. https:\/\/doi.org\/10.7759\/cureus.82579","journal-title":"Cureus"},{"key":"5697_CR45","doi-asserted-by":"publisher","first-page":"10065","DOI":"10.2147\/JIR.S489502","volume":"17","author":"X Li","year":"2024","unstructured":"Li X, Jiang W, Li G, Ding Y, Li H, Sun J, Chen Y, Wang S et al (2024) Inflammatory and nutritional markers as indicators for diagnosing and assessing disease activity in MS and NMOSD. J Inflamm Res 17:10065\u201310078. https:\/\/doi.org\/10.2147\/JIR.S489502","journal-title":"J Inflamm Res"},{"issue":"1","key":"5697_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10162-3","volume":"15","author":"N Eissazade","year":"2025","unstructured":"Eissazade N, Najmi EA, Hemmati D, Mehdizadeh M, Mirzaasgari Z (2025) Carotid intima media thickness, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio in multiple sclerosis. Sci Rep 15(1):24412. https:\/\/doi.org\/10.1038\/s41598-025-10162-3","journal-title":"Sci Rep"},{"key":"5697_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-024-00802-2","author":"SE Fathy","year":"2024","unstructured":"Fathy SE, AbdAllah AM, Helal RY (2024) Neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as predictors of MS severity: a retrospective cohort study. Egypt J Neurol Psychiatr Neurosurg. https:\/\/doi.org\/10.1186\/s41983-024-00802-2","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"issue":"2","key":"5697_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awae269","volume":"148","author":"M Malpetti","year":"2025","unstructured":"Malpetti M, Swann P, Tsvetanov KA, Chouliaras L, Strauss A, Chikaura T, Murley AG, Ashton NJ et al (2025) Blood inflammation relates to neuroinflammation and survival in frontotemporal lobar degeneration. Brain 148(2):493\u2013505. https:\/\/doi.org\/10.1093\/brain\/awae269","journal-title":"Brain"},{"issue":"2","key":"5697_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0271678X241274685","volume":"45","author":"OA Jones","year":"2025","unstructured":"Jones OA, Mohamed S, Hinz R, Paterson A, Sobowale OA, Dickie BR, Parkes LM, Parry-Jones AR (2025) Neuroinflammation and blood-brain barrier breakdown in acute, clinical intracerebral hemorrhage. J Cereb Blood Flow Metab 45(2):233\u2013243. https:\/\/doi.org\/10.1177\/0271678X241274685","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"5697_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/14737175.2021.1935878","volume":"21","author":"R Boltjes","year":"2021","unstructured":"Boltjes R, Knippenberg S, Gerlach O, Hupperts R, Damoiseaux J (2021) Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence. Expert Rev Neurother 21(6):715\u2013725. https:\/\/doi.org\/10.1080\/14737175.2021.1935878","journal-title":"Expert Rev Neurother"},{"key":"5697_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106648","volume":"200","author":"S Agostini","year":"2024","unstructured":"Agostini S, Mancuso R, Citterio LA, Caputo D, Oreni L, Nuzzi R, Pasanisi MB, Rovaris M et al (2024) Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis. Neurobiol Dis 200:106648. https:\/\/doi.org\/10.1016\/j.nbd.2024.106648","journal-title":"Neurobiol Dis"},{"issue":"6\u20137","key":"5697_CR52","doi-asserted-by":"publisher","first-page":"414","DOI":"10.20344\/amp.22380","volume":"38","author":"C Capela","year":"2025","unstructured":"Capela C, Santos E, Palavra F, Guimaraes J, Cerqueira J, Vale J, Sousa L, Batista S et al (2025) Multiple sclerosis disease-modifying treatment algorithms: 2025 positioning of the Portuguese Multiple Sclerosis Study Group. Acta Med Port 38(6\u20137):414\u2013426. https:\/\/doi.org\/10.20344\/amp.22380","journal-title":"Acta Med Port"},{"issue":"1","key":"5697_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/pn-2024-004228","volume":"25","author":"W Rashid","year":"2025","unstructured":"Rashid W, Ciccarelli O, Leary SM, Arun T, Doshi A, Evangelou N, Ford HL, Hobart J et al (2025) Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance. Pract Neurol 25(1):18\u201324. https:\/\/doi.org\/10.1136\/pn-2024-004228","journal-title":"Pract Neurol"},{"key":"5697_CR54","unstructured":"Adil O (2024) New electrochemical platforms for the detection of neurodegenerative disease biomarkers. Southern Illinois University"},{"key":"5697_CR55","unstructured":"Carta E (2025) Bridging cognitive gaps: development of novel diagnostic criteria for MCI in Multiple Sclerosis University of Cagliari"},{"key":"5697_CR56","unstructured":"Odom L (2025) The OGF-OGFr axis in angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. Pennsylvania State University]"},{"key":"5697_CR57","unstructured":"Porcedda C (2025) Conjugated linoleic acid isomers anti-neuroinflammatory effects on activated microglial cells. Universit\u00e0 degli Studi di Cagliari,"},{"key":"5697_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1479864","volume":"12","author":"P Rai","year":"2024","unstructured":"Rai P, Bergmann A (2024) Unraveling the intricate link between cell death and neuroinflammation using Drosophila as a model. Front Cell Dev Biol 12:1479864. https:\/\/doi.org\/10.3389\/fcell.2024.1479864","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"5697_CR59","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1093\/brain\/awae013","volume":"147","author":"F Bagnato","year":"2024","unstructured":"Bagnato F, Sati P, Hemond CC, Elliott C, Gauthier SA, Harrison DM, Mainero C, Oh J et al (2024) Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain 147(9):2913\u20132933. https:\/\/doi.org\/10.1093\/brain\/awae013","journal-title":"Brain"},{"key":"5697_CR60","doi-asserted-by":"publisher","DOI":"10.1177\/17562864241306684","volume":"17","author":"A Dal-Bianco","year":"2024","unstructured":"Dal-Bianco A, Oh J, Sati P, Absinta M (2024) Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. Ther Adv Neurol Disord 17:17562864241306684. https:\/\/doi.org\/10.1177\/17562864241306684","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"5697_CR61","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00415-023-12021-5","volume":"271","author":"D Ontaneda","year":"2024","unstructured":"Ontaneda D, Chitnis T, Rammohan K, Obeidat AZ (2024) Identification and management of subclinical disease activity in early multiple sclerosis: a review. J Neurol 271(4):1497\u20131514. https:\/\/doi.org\/10.1007\/s00415-023-12021-5","journal-title":"J Neurol"},{"key":"5697_CR62","unstructured":"Denissen S (2023) Structural brain damage and cognition in MS: an AI approach. Vrije Universiteit Brussel"},{"issue":"6","key":"5697_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70343","volume":"21","author":"C Delaby","year":"2025","unstructured":"Delaby C, Ladang A, Martinez-Yriarte J, Zecca C, Logroscino G, Kortvelyessy P, Tumani H, Parchi P et al (2025) Clinical use and reporting of neurofilament quantification in neurological disorders: a global overview. Alzheimer\u2019s & Dementia 21(6):e70343. https:\/\/doi.org\/10.1002\/alz.70343","journal-title":"Alzheimer's & Dementia"},{"issue":"4","key":"5697_CR64","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00415-023-12135-w","volume":"271","author":"P Arroyo Pereiro","year":"2024","unstructured":"Arroyo Pereiro P, Munoz-Vendrell A, Leon Moreno I, Bau L, Matas E, Romero-Pinel L, Martinez Yelamos A, Martinez Yelamos S et al (2024) Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing-remitting multiple sclerosis: a 20-year follow-up cohort. J Neurol 271(4):1599\u20131609. https:\/\/doi.org\/10.1007\/s00415-023-12135-w","journal-title":"J Neurol"},{"issue":"8","key":"5697_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13223-9","volume":"272","author":"V Nicolella","year":"2025","unstructured":"Nicolella V, Varelli M, Fasano S, Sirica R, Polito C, Saviano A, Fiorenza M, Novarella F et al (2025) Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis. J Neurol 272(8):495. https:\/\/doi.org\/10.1007\/s00415-025-13223-9","journal-title":"J Neurol"},{"issue":"9","key":"5697_CR66","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1177\/13524585231176732","volume":"29","author":"X Jiang","year":"2023","unstructured":"Jiang X, Shen C, Teunissen CE, Wessels M, Zetterberg H, Giovannoni G, Singh CM, Caba B et al (2023) Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation. Mult Scler 29(9):1070\u20131079. https:\/\/doi.org\/10.1177\/13524585231176732","journal-title":"Mult Scler"},{"key":"5697_CR67","doi-asserted-by":"publisher","DOI":"10.1177\/11795735241249693","volume":"16","author":"J Oh","year":"2024","unstructured":"Oh J, Giacomini PS, Yong VW, Costello F, Blanchette F, Freedman MS (2024) From progression to progress: the future of multiple sclerosis. J Cent Nerv Syst Dis 16:11795735241249693. https:\/\/doi.org\/10.1177\/11795735241249693","journal-title":"J Cent Nerv Syst Dis"},{"key":"5697_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1559172","volume":"16","author":"L Liu","year":"2025","unstructured":"Liu L, Guo K, Yang D (2025) Advances in biomarkers for optic neuritis and neuromyelitis optica spectrum disorders: a multi-omics perspective. Front Neurol 16:1559172. https:\/\/doi.org\/10.3389\/fneur.2025.1559172","journal-title":"Front Neurol"},{"key":"5697_CR69","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1869-24.2024","author":"JR Houchois","year":"2024","unstructured":"Houchois JR, Attwood JE (2024) The challenges of modulating neuroinflammation in Alzheimer\u2019s disease and multiple sclerosis with TREM2 agonistic antibodies. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.1869-24.2024","journal-title":"J Neurosci"},{"issue":"1","key":"5697_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5603\/pjnns.100945","volume":"59","author":"B Zakrzewska-Pniewska","year":"2025","unstructured":"Zakrzewska-Pniewska B, Bartosik-Psujek H, Brola W, Golebiowski M, Kalinowska A, Kulakowska A, Mirowska-Guzel D, Nojszewska M et al (2025) Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society. Neurol Neurochir Pol 59(1):6\u201319. https:\/\/doi.org\/10.5603\/pjnns.100945","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"5697_CR71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00415-023-11971-0","volume":"271","author":"BM Jacobs","year":"2024","unstructured":"Jacobs BM, Tank P, Bestwick JP, Noyce AJ, Marshall CR, Mathur R, Giovannoni G, Dobson R (2024) Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case-control study in an English population-based cohort. J Neurol 271(1):241\u2013253. https:\/\/doi.org\/10.1007\/s00415-023-11971-0","journal-title":"J Neurol"},{"issue":"8","key":"5697_CR72","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214141","volume":"105","author":"N Sahi","year":"2025","unstructured":"Sahi N, Ciccarelli O, Houlden H, Chard DT (2025) Unlocking multiple sclerosis genetics: from susceptibility to severity. Neurology 105(8):e214141. https:\/\/doi.org\/10.1212\/WNL.0000000000214141","journal-title":"Neurology"},{"issue":"9","key":"5697_CR73","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1177\/13524585231189677","volume":"29","author":"RA Marrie","year":"2023","unstructured":"Marrie RA, Chataway J, Bierer BE, Finlayson M, Martinez-Lapiscina EH, Panagoulias J, Sormani MP, Williams MJ et al (2023) Enhancing diversity of clinical trial populations in multiple sclerosis. Mult Scler 29(9):1174\u20131185. https:\/\/doi.org\/10.1177\/13524585231189677","journal-title":"Mult Scler"},{"issue":"1","key":"5697_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J Epidemiol Glob Health 15(1):21. https:\/\/doi.org\/10.1007\/s44197-025-00353-6","journal-title":"J Epidemiol Glob Health"},{"issue":"16","key":"5697_CR75","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00216-025-05859-3","volume":"417","author":"D Tadic","year":"2025","unstructured":"Tadic D, Pires de Lima A, Ricci M (2025) Quality assurance and quality control for human biomonitoring data-focus on matrix reference materials. Anal Bioanal Chem 417(16):3513\u20133528. https:\/\/doi.org\/10.1007\/s00216-025-05859-3","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"5697_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/17576180.2025.2450194","volume":"17","author":"J Wojcik","year":"2025","unstructured":"Wojcik J, Sikorski T, Wang J, Huang Y, Sugimoto H, Baratta M, Ciccimaro E, Green R et al (2025) 2024 white paper on recent issues in bioanalysis: three way-cross validation; urine clinical analysis; automated methods; regulatory queries on plasma protein binding; automated biospecimen management; ELN migration; ultra-sensitivity mass spectrometry (Part 1A - recommendations on advanced strategies for mass spectrometry assays, chromatography, sample preparation and BMV\/regulated bioanalysis Part 1B - regulatory agencies\u2019 inputs on regulated bioanalysis\/BMV). Bioanalysis 17(5):299\u2013337. https:\/\/doi.org\/10.1080\/17576180.2025.2450194","journal-title":"Bioanalysis"},{"issue":"9","key":"5697_CR77","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/17576180.2024.2347153","volume":"16","author":"M Baratta","year":"2024","unstructured":"Baratta M, Jian W, Hengel S, Kaur S, Cunliffe J, Boer J, Hughes N, Kar S et al (2024) 2023 white paper on recent issues in bioanalysis: deuterated drugs; LNP; tumor\/FFPE biopsy; targeted proteomics; small molecule covalent inhibitors; chiral bioanalysis; remote regulatory assessments; sample reconciliation\/chain of custody (PART 1A - recommendations on mass spectrometry, chromatography, sample preparation latest developments, challenges, and solutions and BMV\/regulated bioanalysis PART 1B - regulatory agencies\u2019 inputs on regulated bioanalysis\/BMV, biomarkers\/IVD\/CDx\/BAV, immunogenicity, gene & cell therapy and vaccine). Bioanalysis 16(9):307\u2013364. https:\/\/doi.org\/10.1080\/17576180.2024.2347153","journal-title":"Bioanalysis"},{"issue":"7","key":"5697_CR78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4155\/bio-2024-0024","volume":"16","author":"J Mora","year":"2024","unstructured":"Mora J, Palmer R, Wagner L, Wu B, Partridge M, Meena SI, Smeraglia J, Bivi N et al (2024) 2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA\/NAb Assay\/Reporting Harmonization). Bioanalysis 16(7):77\u2013119. https:\/\/doi.org\/10.4155\/bio-2024-0024","journal-title":"Bioanalysis"},{"key":"5697_CR79","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.17.25322422","author":"G Bsteh","year":"2025","unstructured":"Bsteh G, F\u00f6ttinger F, Ponleitner M, Berek K, Di Pauli F, Heschl B, Wurth S, Deisenhammer F et al (2025) The Austrian MS database and the Austrian MS cohort \u2013 a national effort towards data harmonization and prospective data collection. medRxiv. https:\/\/doi.org\/10.1101\/2025.02.17.25322422","journal-title":"medRxiv"},{"issue":"1","key":"5697_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-024-09452-1","volume":"21","author":"D Wenk","year":"2024","unstructured":"Wenk D, Zuo C, Kislinger T, Sepiashvili L (2024) Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers. Clin Proteomics 21(1):6. https:\/\/doi.org\/10.1186\/s12014-024-09452-1","journal-title":"Clin Proteomics"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05697-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:23:24Z","timestamp":1769682204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05697-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5697"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05697-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received institutional approval from the Ethics Committee of Khoy University of Medical Sciences (Approval No.: IR.KHOY.REC.1403.029). Written informed consent was obtained from all participants. Participation was voluntary, and no participants suffered any direct harm from the procedures used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}